How should we be treating children with congenital hypothyroidism?

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 559-578

  LaFranchi, Stephen H ^a   Austin, Juliana ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Congenital hypothyroidism; Dyshormonogenesis; IQ; L thyroxine; Neurocognitive outcome; Newborn screening; Thyroid dysgenesis

Indexed keywords

ALUMINUM HYDROXIDE; CALCIUM; COLESTYRAMINE; IRON; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; RESIN; SOYBEAN PROTEIN; SUCRALFATE; THYROID HORMONE; THYROTROPIN; THYROXINE;

CLINICAL TRIAL; COGNITION; CONGENITAL HYPOTHYROIDISM; DISEASE SEVERITY; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG CHOICE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; EARLY DIAGNOSIS; FOOD DRUG INTERACTION; HORMONAL THERAPY; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; INCIDENCE; INTELLIGENCE QUOTIENT; LOADING DRUG DOSE; LOW DRUG DOSE; MALABSORPTION; MENTAL DEFICIENCY; NEWBORN SCREENING; PROGNOSIS; PSYCHOMETRY; REVIEW; SOYBEAN MILK; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 34250777878     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.559     Document Type: Review

References (73)

1. Morreale de Escobar G, Obregon MJ, Escobar del Rey. Is neuropsychological development related to maternal hypothyroidism or maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85: 3975-3987.
2. Iskaros J, Pickard M, Evans I, Sinha A, Hardiman P, Ekins R. Thyroid hormone receptor gene expression in the first trimester human fetal brain. Endocrinology 2000; 85: 2620-2623.
3. Chan S, Kachilele S, McCabe CJ, Tannahill LA, Boelaert K, Gittoes NJ, Vissr TJ, Franklyn JA, Kilby MD. Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Dev Brain Res 2002; 138: 109-116.
4. Contempre B, Jauniaux E. Calvo R, Jurkovic D, Campbell S, de Escobar GM. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993; 77: 1719-1722.
5. Calvo R, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contempre B, Morreale de Escobar G. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002; 87: 1768-1777.
6. Haddow JE, Palomaki FE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
7. Vulsma T, Gons MH, deVijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 321: 13-16.
8. Alm J Larsson A, Zetterstrom R. Congenital hypothyroidism in Sweden. Incidence and age at diagnosis. Acta Paediatr Scand 1978; 67: 1-3.
9. Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr 1972; 81: 912-915.
10. DiGeorge A. Disorders of the thyroid gland. In: Nelson WD. Textbook of Pediatrics. Philadelphia, PA: W.B. Saunders Co., 1964; 1268-1282.
11. DiGeorge A. Disorders of the thyroid gland. In: Behrman RE, Vaughan VC III, eds. Nelson Textbook of Pediatrics. Philadelphia, PA: W.B. Saunders Co., 1987; 1193-1207.
12. Dussault JH, Coulombe P, Laberge, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 1975; 86: 670-674.
13. Larsen PR, Merker A, Parlow AF. Immunoassay of human TSH using dried blood samples. J Clin Endocrinol Metab 1976; 42: 987-990.
14. LaFranchi SH, Murphey WH, Foley TP Jr, Larsen PR, Buist NR. Neonatal hypothyroidism detected by the Northwest Regional Screening Program. Pediatrics 1979; 63: 180-191.
15. National Newborn Screening and Genetics Resource Center. National Newborn Screening Report - 2000. Austin, TX: NNSGRC, February 2003.
16. Grant DB, Fuggle P, Tokar S, Smith I. Psychomotor development in infants with congenital hypothyroidism diagnaosed by newborn screening. Acta Med Aust 1992; 19 (Suppl 1): 54-56.
17. Rover JF, Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics 2000; 105: 515-522.
18. von Heppe JH, Krude H, l'Allemand D, Schnabel D, Gruters A. The use of L-T4 as liquid solution improves the practicability and individualized dosage in newborns and infants with congenital hypothyroidism. J Pediatr Endocrinol Metab 2004; 17: 967-974.
19. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest 1995; 96: 2828-2838.
20. Obregón MJ, Ruiz de Oña C, Calvo R, Escobar del Rey F, Morreale de Escobar G. Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology 1991; 129: 2663-2673.
21. Hays MT. Thyroid hormone and the gut. Endocr Res 1988; 14: 203-224.
22. Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll Nutr 1997; 16: 280-282.
23. Conrad SC, Chiu H, Silverman BL. Soy formula complicates management of congenital hypothyroidism. Arch Dis Child 2004; 89: 37.
24. American Academy of Pediatrics; Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association; Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society; Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, Varma SK. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006; 117: 2290-2303.
25. Glorieux J, Desjardins M, Letarte J, Morissette J, Dussault JH. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res 1988; 24: 6-8.
26. Rovet JF, Ehrlich RM. Long-term effects of 1-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995; 126: 380-386.
27. Touati G, Leger J, Toublanc JE, Farriaux JP, Stuckens C, Ponte C, David M, Rochiccioli P, Porquet D, Czernichow P. A thyroxine dosage of 8 μg/ kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997; 156: 94-98.
28. New England Congenital Hypothyroidism Collaborative. Screening for congenital hypothyroidism [Letter]. Lancet 1986; ii: 403.
29. Germak JA, Foley TP Jr. Longitudinal assessment of l-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990; 117: 211.
30. Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di Maio S, Tenore A. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002; 12: 45-52.
31. Selva K, Mandel SH, Rein L, Miyahira R, Skeels M, LaFranchi S. Initial treatment dose of l-thyroxine in congenital hypothyroidism. J Pediatr 2002; 141: 786-792.
32. Selva KA, Harper A, Downs A, Blasco PA, LaFranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatrics 2005; 147: 775-780.
33. New England Congenital Hypothyroidism Collaborative. Neonatal hypothyroidism screening: status of patients at 6 years of age. J Pediatr 1985; 107: 915-919.
34. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995; 126: 380-386.
35. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112: 923-930.
36. Connelly JF, Rickards AL, Coakley JC, Price GJ, Francis I, Mathur KS, Wolfe R. Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: Treatment, progress and outcome. J Pediatr Endocrinol Metab 2001; 14: 1611-1634.
37. Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics 2005; 115: 52-57.
38. Boileau P, Bain P, Rives S, Toublan JE. Earlier onset of treatment or increment in 1-T4 dose in screened congenital hypothyroidism: which was the more important factor for IQ at 7 years? Horm Res 2004; 61: 228-233.
39. Salerno M, Di Maio S, Militerni R, Argenziano A, Valerio G, Tenore A. Prognostic factors in the intellectual development at 7 years of age in children with congenital hypothyroidism. J Endocrinol Invest 1995; 18: 774-779.
40. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136: 292-297.
41. Bongers-Schokking JJ, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 2005; 147: 768-774.
42. Schwartz IR, Turner K, Kruger T, Bennett D, Howard CP, Grunt JA. Neuropsychological outcome in children with congenital hypothyroidism treated with varying amounts of levothyroxine during the first 2 years of life. Int Pediatr 1994; 9: 254-259.
43. Tillotson SL, Fuggle PW Smith I, Ades AE, Grant DB. Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. Br Med J 1994; 309: 440-445.
44. Glorieux J, Dussualt J, Van Vliet G. Intellectual development at age 12 years of children with congenital hypothyroidism diagnosed by newborn screening. J Pediatr 1992; 121: 581-584.
45. Dubuis JM, Glorieux J, Richer F, Deal CL, Dussault JH, Van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996; 81: 222-227.
46. Kreisner E, Schermann L, Camargo-Neto E, Gross JL. Predictors of intellectual outcome in a cohort of Brazilian children with congenital hypothyroidism. Clin Endocrinol 2004; 60: 250-255.
47. Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004; 144: 747-752.
48. Rovet J, Ehrlich R, Sorbara D. Intellectual outcome in children with fetal hypothyroidism. J Pediatr 1987; 110: 700-704.
49. Rovet JF, Ehrlich RM, Sorbara DL. Neurodevelopment in infants and preschool children with congenital hypothyroidism: etiological and treatment factors affecting outcome. J Pediatr Psychol 1992; 17: 187-213.
50. Rovet JF. Congenital hypothyroidism: long-term outcome. Thyroid 1999; 9: 741-748.
51. Song SI, Daneman D, Rovet J. The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. J Dev Behav Pediatr 2001; 22: 376-383.
52. Salerno M, Militerni R, Di Maio S, Bravaccio C, Gasparini N, Tenore A. Intellectual outcome at 12 years of age in congenital hypothyroidism. Eur J Endocrinol 1999; 141: 105-110.
53. Chiovato L, Giusti L, Tonacchera M, Ciampi M, Mammoli C, Lippi F, Lapi P, Bargagna S, Dini P, Ferretti G, et al. Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism. J Endocrinol Invest 1991; 14: 957-964.
54. Bargagna S, Canepa G, Costagli C, Dinetti D, Marcheschi M, Millepiedi S, Montanelli L, Pinchera A, Chiovato L. Neuropsychological follow-up in early-treated congenital hypothyroidism: a problem-oriented approach. Thyroid 2000; 10: 243-249.
55. Kooistra L, Laane C, Vulsma T, Schellekens JMH, van der Meere JJ, Kalverboer AF. Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. J Pediatr 1994; 124: 903-909.
56. Kempers MJE, van der Sluijs Veer L, Nijhuis-van der Sanden MW, Kooistra L, Wiedijk BM, Faber I, Last BF, de Vijlder JJ, Grootenhuis MA, Vulsma T. Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab 2006; 91: 418-424.
57. Illig R, Largo RH, Weber M, Augsburger T, Lipp A, Wissler D, Perrenoud AE, Torresani T. Sixty children with congenital hypothyroidism detected by neonatal thyroid: mental developmental at 1, 4, and 7 years: a longitudinal study. Acta Endocrinol 1986; Suppl 279: 346-353.
58. Hsiao PH, Chiu YN, Tsai WY, Su SC, Lee JS, Soong WT. Intellectual outcome of patients with congenital hypothyroidism detected by neonatal screening. J Formosan Med Assoc 2001; 100: 40-44.
59. Murphy G, Hulse JA, Jackson D, Tyrer P, Glossop J, Smith I, Grant D. Early treated hypothyroidism: development at 3 years. Arch Dis Child 1986; 61: 761-765.
60. Murphy GH, Hulse JA, Smith I, Grant DB. Congenital hypothyroidism: physiological and psychological factors in early development. J Child Psych Psychiat 1990; 31: 711-725.
61. Fuggle PW, Grant DB, Smith I, Murphy G. Intelligence, motor skills and behavior at 5 years in early-treated congenital hypothyroidism. Eur J Pediatr 1991; 150: 570-574.
62. Simons WF, Fuggle PW, Grant DB, Smith I. Intellectual development at 10 years in early treated congenital hypothyroidism. Arch Dis Child 1994; 71: 232-234.
63. Campos SP, Sandberg DE, Barrick C, Voorhess ML, MacGillivray MH. Outcome of lower l-thyroxine dose for treatment of congenital hypothyroidism. Clin Pediatr 1995; 34: 514-520.
64. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI. Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993; 123: 889-905.
65. Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T, Tenore A. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001; 145: 377-383.
66. Weichsel ME Jr. Thyroid hormone replacement therapy in the perinatal period: neurologic considerations. J Pediatr 1978; 92: 1035-1038.
67. Rovet J, Ehrlich RM, Sorbara DL. Effect of thyroid hormone levels on temperament in infants with congenital hypothyroidism detected by screening of neonates. J Pediatr 1989; 114: 63-68.
68. Rovet, J, Alvarez, M. Thyroid hormone and attention in congenital hypothyroidism. J Pediatr Endocrinol Metab 1996; 9: 63-66.
69. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid diseases. Thyroid 2003; 13: 3-126.
70. Fisher DA, Schoen EJ, LaFranchi S, Mandel SH, Nelson JC, Carlton EI, Goshi JH. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 2000; 85: 2722-2727.
71. Kempers MJ, van Trotsenburg AS, van Tijn DA, Bakker E, Wiedijk BM, Endert E, de Vijlder JJ, Vulsma T. Disturbance of the fetal thyroid hormone state has long-term consequences for treatment of thyroidal and central congenital hypothyroidism. J Clin Endocrinol Metab 2005; 90: 4094-5000.
72. Delange F, Heidemann P, Bourdoux P, Larsson A, Vigneri R, Klett M, Beckers C, Stubbe P. Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol Neonate 1986; 49: 322-330.
73. Kohler B Schnabel D, Biebermann H, Gruters A. Transient congenital hypothyroidism and hyperthyrotropinemia: normal thyroid function and physical development at ages of 6-14 years. J Clin Endocrinol Metab 1996; 81: 1563-1567.